Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies with attractive risk-reward profiles. Our valuation framework helps you find stocks with the right balance of growth and value characteristics for your portfolio. We provide P/E analysis, PEG ratios, and relative valuation metrics for comprehensive valuation coverage. Find value in growth with our comprehensive valuation analysis and multiples tools for growth at a reasonable price strategies.
As of 2026-04-20, Theriva Biologics Inc. (TOVX) is trading at a current price of $0.44, marking a 70.30% gain in recent trading sessions. This analysis breaks down the key market context driving recent price action, critical technical support and resistance levels, and potential near-term scenarios for the biotech stock, with no investment recommendations included. The sharp upward move has drawn elevated market attention to TOVX, as the stock has outperformed most of its small-cap biotech peers
Is Theriva Biologics (TOVX) stock breaking out today (Investors Pile In) 2026-04-20 - Popular Trader Picks
TOVX - Stock Analysis
3219 Comments
936 Likes
1
Dolen
Legendary User
2 hours ago
Did you just bend reality with that? 🌌
👍 76
Reply
2
Greidi
Senior Contributor
5 hours ago
My brain processed 10% and gave up.
👍 295
Reply
3
Krysteen
Registered User
1 day ago
Missed it completely… sigh.
👍 122
Reply
4
Kahmiyah
Influential Reader
1 day ago
The market shows relative strength in growth-oriented sectors.
👍 126
Reply
5
Teaghan
Registered User
2 days ago
I need sunglasses for all this brilliance. 🕶️
👍 149
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.